Positive News - 500 Beiträge pro Seite

[HaseCaesar]

Das hört sich sehr gut. Enormer Anstieg gestern bei hohem Volumen. Auch charttechnisch dürfte die Aktie interessant sein.

Hansen Medical Inc. said Thursday it will receive upfront payments of $29 million and future payments of up to $78 million in a patent and license deal with a subsidiary of Koninklijke Philips Electronics N.V.Mountain View-based Hansen Medical (NASDAQ:HNSN) said Philips will develop and commercialize the non-robotic applications of Hansen's fiber optic shape sensing and localization (FOSSL) technology.

"FOSSL is a potentially disruptive visualization technology that employs a fiber optic sensor designed to allow physicians to identify both the shape and position of catheters and other tools used in minimally invasive procedures. FOSSL has the potential to enable more efficient and precise control and continuous tracking of flexible tools used in these procedures," the company said.

FOSSL is being developed by Hansen Medical and Luna Innovations Inc.

Under the terms of the agreements, Philips has the exclusive right to develop and commercialize the FOSSL technology in the non-robotic vascular, endoluminal and orthopedic fields.

Read more: Hansen Medical could get $107M in Philips deal | Silicon Valley / San Jose Business Journal

siehe: http://www.bizjournals.com/sanjose/news/2011/02/03/hansen-me…

[HaseCaesar]

Meines Erachtens bleibt die Story um Hansen und des Einsatzes der von Hansen entwickelten Medizintechnik spannend.

Hansen Medical Announces 2010 Fourth Quarter and Full-Year Results Conference Call
.
Companies:Hansen Medical, Inc..Related Quotes
Symbol Price Change
HNSN 2.05 0.00


{"s" : "hnsn","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Hansen Medical, Inc. On Tuesday February 8, 2011, 6:00 am
MOUNTAIN VIEW, CA--(Marketwire - 02/08/11) - Hansen Medical, Inc. (NASDAQ:HNSN - News), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2010 after market close on Wednesday, February 23, 2011.

Bruce Barclay, president and chief executive officer will host a conference call at 5:00 p.m. ET (2:00 p.m. PT) on February 23, 2011 to discuss the company's results. The call may be accessed by dialing 877-941-2322 (480-629-9715 for international callers) and via the Internet in the Investor Relations section of Hansen Medical's website at www.hansenmedical.com. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. Following the call, a webcast replay will be available on Hansen Medical's website, and an audio replay will also be available by calling 877-870-5176 (858-384-5517 for international callers) and entering the access code 4409948. The audio replay will be available through March 2, 2011.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company's Sensei® system and its Sensei X Robotic Catheter System were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the United States, the Sensei System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei and Sensei X systems for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established during EP procedures, such as guiding catheters in the treatment of AF. In the European Union, the Sensei and the Sensei X systems are cleared for use during EP procedures, such as guiding catheters in the treatment of AF, and the Lynx™ robotic catheter is cleared for AF ablation. The Company's investigational flexible catheter vascular robotic system requires regulatory filings and approval and is not commercially available. Additional information can be found at www.hansenmedical.com.

http://finance.yahoo.com/news/Hansen-Medical-Announces-2010-…

[HaseCaesar]

Ich denke, die Story um Hansen und der von Hansen entwickelten Medizintchnik bleibt spannend. Schaun wir mal, wie sich die letzten News auf den Ausblick auswirken und ob die Zahlen auch für das 4. Quartal und das vergangene Jahr passen.



Hansen Medical Announces 2010 Fourth Quarter and Full-Year Results Conference Call
.
Companies:Hansen Medical, Inc..Related Quotes
Symbol Price Change
HNSN 2.05 0.00


{"s" : "hnsn","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Hansen Medical, Inc. On Tuesday February 8, 2011, 6:00 am
MOUNTAIN VIEW, CA--(Marketwire - 02/08/11) - Hansen Medical, Inc. (NASDAQ:HNSN - News), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that it will release its financial and operating results for the fourth quarter and full year ended December 31, 2010 after market close on Wednesday, February 23, 2011.

Bruce Barclay, president and chief executive officer will host a conference call at 5:00 p.m. ET (2:00 p.m. PT) on February 23, 2011 to discuss the company's results. The call may be accessed by dialing 877-941-2322 (480-629-9715 for international callers) and via the Internet in the Investor Relations section of Hansen Medical's website at www.hansenmedical.com. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. Following the call, a webcast replay will be available on Hansen Medical's website, and an audio replay will also be available by calling 877-870-5176 (858-384-5517 for international callers) and entering the access code 4409948. The audio replay will be available through March 2, 2011.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company's Sensei® system and its Sensei X Robotic Catheter System were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the United States, the Sensei System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei and Sensei X systems for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established during EP procedures, such as guiding catheters in the treatment of AF. In the European Union, the Sensei and the Sensei X systems are cleared for use during EP procedures, such as guiding catheters in the treatment of AF, and the Lynx™ robotic catheter is cleared for AF ablation. The Company's investigational flexible catheter vascular robotic system requires regulatory filings and approval and is not commercially available. Additional information can be found at www.hansenmedical.com.

http://finance.yahoo.com/news/Hansen-Medical-Announces-2010-…

[KimLanners]

Sehr genau! Hansen hat potential auf 1500%!

Solarworld, Kongzhong, Hansen, Blockbuster!

gg